RARRES2 and polycystic ovary syndrome: Interestingly, our data show that VD3 treatment has no effect on plasma RARRES2 levels; however, we observed that after VD3 supplementation in PCOS rats, the concentration of RARRES2 was significantly reduced to the control level.